Halozyme Therapeutics Inc (HALO)
44.71
-0.68
(-1.50%)
USD |
NASDAQ |
May 17, 16:00
44.73
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Cash and Short Term Investments (Quarterly): 463.45M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 463.45M |
December 31, 2023 | 336.00M |
September 30, 2023 | 483.28M |
June 30, 2023 | 348.28M |
March 31, 2023 | 275.61M |
December 31, 2022 | 362.79M |
September 30, 2022 | 265.58M |
June 30, 2022 | 209.36M |
March 31, 2022 | 786.14M |
December 31, 2021 | 740.92M |
September 30, 2021 | 815.92M |
June 30, 2021 | 755.31M |
March 31, 2021 | 764.31M |
December 31, 2020 | 368.01M |
September 30, 2020 | 346.71M |
June 30, 2020 | 385.45M |
March 31, 2020 | 368.18M |
December 31, 2019 | 421.26M |
September 30, 2019 | 238.00M |
June 30, 2019 | 287.46M |
March 31, 2019 | 328.72M |
December 31, 2018 | 354.53M |
September 30, 2018 | 364.37M |
June 30, 2018 | 398.89M |
March 31, 2018 | 433.69M |
Date | Value |
---|---|
December 31, 2017 | 469.21M |
September 30, 2017 | 316.92M |
June 30, 2017 | 297.53M |
March 31, 2017 | 178.98M |
December 31, 2016 | 204.98M |
September 30, 2016 | 221.05M |
June 30, 2016 | 229.99M |
March 31, 2016 | 238.64M |
December 31, 2015 | 108.34M |
September 30, 2015 | 123.72M |
June 30, 2015 | 140.72M |
March 31, 2015 | 128.50M |
December 31, 2014 | 135.62M |
September 30, 2014 | 134.46M |
June 30, 2014 | 147.65M |
March 31, 2014 | 164.49M |
December 31, 2013 | 71.50M |
September 30, 2013 | 65.31M |
June 30, 2013 | 76.01M |
March 31, 2013 | 87.43M |
December 31, 2012 | 99.50M |
September 30, 2012 | 87.61M |
June 30, 2012 | 102.04M |
March 31, 2012 | 116.61M |
December 31, 2011 | 52.83M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
209.36M
Minimum
Jun 2022
815.92M
Maximum
Sep 2021
451.10M
Average
368.10M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Novavax Inc | 480.59M |
Globus Medical Inc | 434.47M |
Denali Therapeutics Inc | 936.87M |
AIM ImmunoTech Inc | 13.07M |
Protalix BioTherapeutics Inc | 48.49M |